← Back to patent-cliff list
双氯芬酸钠/盐酸乙哌立松
Tier C — Watch / tradeDiclofenac Sodium/Eperisone Hydrochloride
卫材株式会社
Originator
2012
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：VDCCs、COXs
Brand：Eprisan D SR
Indications (approved)：背痛
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Diclofenac Sodium/Eperisone Hydrochloride?
Approved indications include: 背痛.
When does the Diclofenac Sodium/Eperisone Hydrochloride patent expire?
No public expiry year is available for Diclofenac Sodium/Eperisone Hydrochloride yet; this page updates once verified.
How do I get a quote for Diclofenac Sodium/Eperisone Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24